C3.ai First Quarter 2026 Earnings: Misses Expectations

C3.ai (NYSE:AI) First Quarter 2026 Results

Key Financial Results

• Revenue: US$70.3m (down 19% from 1Q 2025).
• Net loss: US$116.8m (loss widened by 86% from 1Q 2025).
• US$0.86 loss per share (further deteriorated from US$0.50 loss in 1Q 2025).

AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early.

All figures shown in the chart above are for the trailing 12 month (TTM) period

C3.ai Revenues and Earnings Miss Expectations

Revenue missed analyst estimates by 25%. Earnings per share (EPS) also missed analyst estimates by 38%.

Looking ahead, revenue is forecast to grow 7.5% p.a. on average during the next 3 years, compared to a 13% growth forecast for the Software industry in the US.

Performance of the American Software industry.

The company's shares are down 6.9% from a week ago.

Risk Analysis

You should learn about the 3 warning signs we've spotted with C3.ai (including 1 which is a bit concerning).

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.